SARA GRATER: Open Payments
NPI 1831573799 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,045 in 269 payments from 42 companies in 2025. Trend: 2023 $4,998 · 2024 $5,955 · 2025 $5,045
Food & beverage: $4,637Education: $258Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 28 | $405 |
| JAZZ PHARMACEUTICALS INC. | 12 | $367 |
| Biogen, Inc. | 12 | $344 |
| Teva Pharmaceuticals USA, Inc. | 13 | $343 |
| ABBVIE INC. | 26 | $320 |
| HARMONY BIOSCIENCES LLC | 18 | $286 |
| EMD Serono, Inc. | 16 | $253 |
| Novartis Pharmaceuticals Corporation | 17 | $244 |
| ACADIA Pharmaceuticals Inc | 12 | $224 |
| ARGENX US, INC. | 6 | $198 |
Products named: INGREZZA, TYSABRI, XYWAV, KESIMPTA, WAKIX, AUSTEDO XR, QULIPTA, NUPLAZID.
Industry payments across OH — which companies pay providers there.
